INSIGHTS ON LIQUID DOSE MANUFACTURING

• Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications

  Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.

• What Is Aseptic Processing?

  Aseptic processing sterilizes products and packaging separately, then combines them in a sterile environment. See how this method ensures safety, extends shelf life, and protects medicines from contamination.

• Low Temperature Storage Containment For Vial And Syringe Systems

  With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

• CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever

  As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.

• Water For Injection: Strategic Utility And The Case For Outsourcing

  3/9/2026

  Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.

• Lyophilization To Enable Drug Products Containing Labile Molecules

  6/6/2025

  Develop lyophilized formulations to overcome stability challenges and significantly extend the shelf life of sensitive therapeutic products.

• Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality

  5/12/2026

  Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.

• Contamination Control Strategies: Comparing Cleanrooms, RABS, Isolators

  10/20/2025

  Sterile manufacturing relies on three main contamination control strategies (CCSs): cleanrooms, RABS, and isolators. Understand how each system compares in sterility assurance, startup cost, and operational flexibility.

• How To Use Enzyme Indicators In An Aseptic Production Environment

  6/30/2026

  Discover how transitioning to quantitative validation data allows engineering teams to optimize decontamination timelines, slash system downtime, and minimize product carryover risks.